Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Cam Gallagher
AddedMar 31, 2024
UpdatedMay 31, 2026
Cam Gallagher

Cam Gallagher

Board Member, Ocuphire Pharma

CrunchbaseLinkedIn

Cam Gallagher's Career

Ocuphire Pharma
Ocuphire Pharma

Farmington Hills, MI, US

Board Member· Board
Oncternal Therapeutics
Oncternal Therapeutics

San Diego, CA, US

Board Member· Board
Diogenix
Diogenix
Founder
Nerveda
Nerveda

San Diego, CA, US

Founder
Zenopharm
Zenopharm

New Orleans, LA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Cam Gallagher's Career

Ocuphire Pharma
Ocuphire Pharma
Public$24.6M82018Farmington Hills, MI, US
Board Member· Board

Leadership at Ocuphire Pharma

Sean AinsworthSean AinsworthBoard Member
Mina SoochMina SoochBoard Member
Rick RodgersRick RodgersBoard Member
Alan MeyerAlan MeyerBoard Member
Susan BentonSusan BentonBoard Member
Dr James S J ManusoDr James S J ManusoBoard Member

Similar to Ocuphire Pharma

Ocumension TherapeuticsOcumension TherapeuticsShanghai, Shanghai, CNPharmaceuticals, Therapiesest. 2017Ocumension TherapeuticsShanghai, Shanghai, CN · est. 2017

Ocumension Therapeutics: A dedicated platform for developing and commercializing ophthalmic therapies.

Public · $200M175
OcuCure TherapeuticsOcuCure TherapeuticsRoanoke, VA, USEye Drops, Pharmaceuticalsest. 2005OcuCure TherapeuticsRoanoke, VA, US · est. 2005

OcuCure Therapeutics: Developing innovative eye drops for age-related and diabetic eye diseases since 2005.

Public · $3.3M8
EyePointEyePointWatertown, MA, USDrug Devicesest. 2008EyePointWatertown, MA, US · est. 2008

EyePoint Pharmaceuticals, a global biopharmaceutical firm, develops drug devices for chronic eye disorders.

Public · $653.8M144
Ocular TherapeutixOcular TherapeutixBedford, MA, USOphthalmic Therapiesest. 2006Ocular TherapeutixBedford, MA, US · est. 2006

Ocular Therapeutix, Inc.: Global biopharma innovator in hydrogel-based ophthalmic therapies.

Public · $386.5M274
Oncternal Therapeutics
Oncternal Therapeutics
Public$132M302013San Diego, CA, US
Board Member· Board

Leadership at Oncternal Therapeutics

Lauren OtsukiLauren OtsukiFounder
Michael G. CarterMichael G. CarterBoard Member
William R. LaRueWilliam R. LaRueBoard Member
Daniel KisnerDaniel KisnerBoard Member
David F. HaleDavid F. HaleBoard Member
Charles TheuerCharles TheuerBoard Member
Diogenix
Diogenix
Public$3.2M82007
Founder

Leadership at Diogenix

Antonius SchuhAntonius SchuhBoard Member

Similar to Diogenix

NeodiagnostixNeodiagnostixRockville, MD, USDiagnostics, Genomicsest. 2005NeodiagnostixRockville, MD, US · est. 2005

NeoDiagnostix, a Maryland-based medical organization, pioneers personalized cancer care through advanced genomics and diagnostics.

Seed · $1.5M9
SenGenixSenGenixDurham, NC, USDiagnostic Testsest. 2012SenGenixDurham, NC, US · est. 2012

SenGenix: Developing fast, accurate, low-cost point-of-care diagnostic tests since 2012.

Series A · $11.2M6
ProteogenixProteogenixCosta Mesa, CA, USDiagnostic Testsest. 2002ProteogenixCosta Mesa, CA, US · est. 2002

ProteoGenix Inc. develops and commercializes diagnostic tests for pregnancy-related complications.

Series A · $39.2M30
SynapDxSynapDxLexington, MA, USDiagnostic Testsest. 2010SynapDxLexington, MA, US · est. 2010

SynapDX: Pioneering early autism detection through blood-based diagnostic tests.

Series B · $32.4M11
Nerveda
Nerveda
Series B$14.1M52007San Diego, CA, US
Founder
Zenopharm
Zenopharm
Series B$18.3M52014New Orleans, LA, US
Co-Founder

Leadership at Zenopharm

Guangdi WangGuangdi WangCEO
Shilong ZhengShilong ZhengCo-Founder
Qiu ZhongQiu ZhongCo-Founder

Cam Gallagher's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Cam Gallagher

James FoghtJames FoghtBoard Member · OncolyzeGreg HallmanGreg HallmanCo-Founder · OcupathPeter SvennilsonPeter SvennilsonFounder · The Column GroupTerry OpgenorthTerry OpgenorthFounder · VetDC